Treatment of leucopenia with pure Astragalus preparation

Xiao-Sheng Weng

doi:10.1007/BF02934209

Your Location：

Home >

Browse articles >

Treatment of leucopenia with pure Astragalus preparation

Updated：2021-08-27

- Treatment of leucopenia with pure Astragalus preparation
- Chinese Journal of Integrative Medicine Vol. 2, Issue 1, Pages: 15-18(1996)
- Affiliations：
  
  Wuxi Hospital of Traditional Chinese Medicine,Jiangsu
- Author bio：
- Funds：
- DOI：10.1007/BF02934209
  CLC：
- Published：1996，
Scan for full text
Weng, XS. Treatment of leucopenia with pure Astragalus preparation., CJIM 2, 15–18 (1996). https://doi.org/10.1007/BF02934209

Xiao-Sheng Weng. Treatment of leucopenia with pure Astragalus preparation. [J]. Chinese Journal of Integrative Medicine 2(1):15-18(1996)
Weng, XS. Treatment of leucopenia with pure Astragalus preparation., CJIM 2, 15–18 (1996). https://doi.org/10.1007/BF02934209 DOI：

Xiao-Sheng Weng. Treatment of leucopenia with pure Astragalus preparation. [J]. Chinese Journal of Integrative Medicine 2(1):15-18(1996) DOI： 10.1007/BF02934209.

摘要

This article reports the effects of pure Radix Astragali preparation (PAP) in treating 115 cases of leucopenia. These cases were divided at random into two groups. Group A (58 cases) was treated by highly concentrated PAP

every 10 ml equal to 15 grams of Radix Astragali (RA)

group B (57 cases) was treated by lowly concentrated PAP

every 10 ml equal to 5 g of RA. The patients took the PAP twice a day

10 ml each time. The course of treatment was 8 weeks for both groups. The results showed there was an obvious increase of the WBC counts in both groups after treatment (P<0.001). The effectiveness in group A was 82.76%

while in group B 47.37%

they were statistically different (P<0.01). The total effective rate of the 2 groups was 65.22%. According to the comparison average WBC counts after treatment of group A was significantly higher than that of group B (P<0.05). The results were dose-dependent. The author holds that RA is an effective drug in treating leucopenia

and increasing the dosage could enhance its effectiveness.

Abstract

every 10 ml equal to 15 grams of Radix Astragali (RA)

group B (57 cases) was treated by lowly concentrated PAP

every 10 ml equal to 5 g of RA. The patients took the PAP twice a day

while in group B 47.37%

and increasing the dosage could enhance its effectiveness.

关键词

leucopeniaRadix Astragaliconcentration of drug

Keywords

leucopeniaRadix Astragaliconcentration of drug

references

FULL TEXT LINK

More>

Views

725

Downloads

CSCD

Alert me when the article has been cited

Submit

Tools

Publicity Resources

Progress in the research of Radix Astragali in treating chronic heart failure: Effective ingredients, dose-effect relationship and adverse reaction

Prevention of tumor necrosis factor-a induced insulin resistance by Radix Astragali

Effects of Radix Astragali on left ventricular function and oxygen free radicals in acute myocardial infarction patients and its mechanism of cardiotonic action

Effect of Radix Astragali in combined therapy on T-lymphocyte subsets in patients with viral myocarditis

A study on various symptoms of chronic hepatitis treated with radix astragali and its regulative effect to levels of serum hormone

Related Author

No data

Related Institution

Department of Cardiovascular Diseases, Wuxi Municipal Hospital of Traditional Chinese Medicien, Wuxi City

Xiyuan Hospital, China Academy of Chinese Medical Sciences

Department of Endocrinology, Changhai Hospital, The Second Military Medical University

Departent of Emergency

Department of Cardiology Dongzhimen Hospital, Beijing University of Traditional Chinese Medicine

Address：1 Caochang, xiyuan, Beijing, People's Republic of China Postal code：100091
Tel：010-62886827, 62877592 Fax：010-62874291
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备05067934号-1 京公网安备11010802024621
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰